|Articles|September 7, 2021

A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial

Brad Hertz is a BRCA2 previvor who enrolled himself in a clinical trial for prostate cancer.

Clinical trials and research studies are how we move science and research forward. During Prostate Cancer Awareness Month we honor all those with, or at risk for, prostate cancer and we share this story of Brad Hertz, BRCA2 previvor who enrolled himself in a prostate cancer clinical trial at the National Institutes of Health.

Related to this article

mammogram
Long-term Kisqali data, a new targeted drug, blood tests and AI are among the topics to watch at the 2026 San Antonio Breast Cancer Symposium.